Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.31 |
| ▸ | KDM4A | O75164 | 1/20 | 0.31 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.31 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28972282 | 1.00 | LMNA (0.46) | LMNAKDM4CKDM4APHF8KDM2A | |
| SCHEMBL14656811 | 0.97 | LMNA (0.48) | LMNA | |
| SCHEMBL17607540 | 0.92 | LMNA (0.48) | LMNA | |
| SCHEMBL5086519 | 0.81 | OPRM1 (0.46) | LMNA | |
| SCHEMBL5613428 | 0.81 | OPRM1 (0.46) | LMNA | |
| SCHEMBL5613268 | 0.81 | OPRM1 (0.46) | LMNA | |
| SCHEMBL5090277 | 0.81 | OPRM1 (0.46) | LMNA | |
| SCHEMBL5090691 | 0.81 | OPRM1 (0.46) | LMNA | |
| SCHEMBL9211579 | 0.81 | OPRM1 (0.46) | LMNA | |
| SCHEMBL5613655 | 0.81 | OPRM1 (0.46) | LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240132728-A1 | Bio-Based Coalescing Solvents | BATTELLE MEMORIAL INSTITUTE | 2024-04-25 | — | — | US | disclosed |
| EP-4259731-A2 | BIO-BASED COALESCING SOLVENTS | Battelle Memorial Institute (US) | 2023-10-18 | — | — | EP | disclosed |
| WO-2022132820-A2 | BIO-BASED COALESCING SOLVENTS | BATTELLE MEMORIAL INSTITUTE (US) | 2022-06-23 | — | — | WO | disclosed |
| US-10551345-B2 | Poly and copoly(N-vinylamide)s and their use in capillary electrophoresis | APPLIED BIOSYSTEMS, LLC (US) | 2020-02-04 | — | — | US | disclosed |
| EP-2496615-B1 | ENVIRONMENTALLY FRIENDLY COLORANT COMPOSITIONS AND LATEX PAINTS/COATINGS | MOORE BENJAMIN & CO (US) | 2019-09-18 | — | — | EP | disclosed |
| EP-1910458-B1 | LATEX PAINT FILM RESISTANT TO ADVERSE EFFECTS OF WATER, AND COMPOSITIONS AND METHODS FOR MAKING SAME | BENJAMIN MOORE&CO (US) | 2018-02-21 | — | — | EP | disclosed |
| US-20180030237-A1 | Environmentally Friendly Colorant Compositions and Latex Paints/Coatings | COLUMBIA INSURANCE CO (US) | 2018-02-01 | — | — | US | disclosed |
| US-20170356877-A1 | POLY AND COPOLY(N-VINYLAMIDE)S AND THEIR USE IN CAPILLARY ELECTROPHORESIS | APPLIED BIOSYSTEMS, LLC (US) | 2017-12-14 | — | — | US | disclosed |
| US-9815961-B2 | Environmentally friendly colorant compositions and latex paints/coatings | COLUMBIA INSURANCE COMPANY (US) | 2017-11-14 | — | — | US | disclosed |
| US-9744236-B2 | Photolabile compounds | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2017-08-29 | — | — | US | disclosed |
| WO-2005044281-A1 | BAICALIN AND ITS DERIVATIVES AS A TREATMENT FOR SARS CORONA VIRUS INFECTION OR OTHER RELATED INFECTIONS | THE UNIVERSITY OF HONG KONG (CN) | 2005-05-19 | — | — | WO | disclosed |
| US-6864261-B2 | Therapeutic agents useful for treating pain | EURO-CELTIQUE S.A. (LU) | 2005-03-08 | — | — | US | disclosed |
| WO-2005019353-A2 | COPOLYMER SURFACTANTS | COLUMBIA INSURANCE COMPANY (US) | 2005-03-03 | — | — | WO | disclosed |
| US-20050039635-A1 | Copolymer surfactants | BENJAMIN MOORE & CO. | 2005-02-24 | — | — | US | disclosed |
| US-20050025741-A1 | Copolymers with (meth)acrylamides; improved separation of polynucleotides | APPLIED BIOSYSTEMS, LLC | 2005-02-03 | — | — | US | disclosed |
| WO-2004104054-A1 | POLY AND COPOLY (N-VINYLAMIDE)S AND THEIR USE IN CAPILLARY ELECTROPHORESIS | APPLERA CORPORATION (US) | 2004-12-02 | — | — | WO | disclosed |
| US-20040127501-A1 | Therapeutic agents useful for treating pain | EURO-CELTIQUE S.A. (LU) | 2004-07-01 | — | — | US | disclosed |
| WO-2004029044-A1 | PYRIMIDINE COMPOUNDS AS THERAPEUTIC AGENTS | EURO-CELTIQUE, S.A. (LU) | 2004-04-08 | — | — | WO | disclosed |
| US-20040053914-A1 | Therapeutic agents useful for treating pain | PURDUE PHARMA L.P. | 2004-03-18 | — | — | US | disclosed |
| WO-2003093236-A1 | 1-(PYRID-2-YL)-PIPERAZINE COMPOUNDS AS METABOTROPIC GLUTAMATE RECEPTOR INHIBITOR | EURO-CELTIQUE, S.A. (LU) | 2003-11-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040053914-A1 | Therapeutic agents useful for treating pain | SMN1; SMN2, OPRM1, PSEN1 | LMNA 918/4885KDM4C 3452/4885KDM4A 3412/4885 |
| US-20040127501-A1 | Therapeutic agents useful for treating pain | CACNA1A, GRIN2A, HTT | LMNA 745/4885KDM4C 3351/4885KDM4A 3835/4885 |
| US-20050025741-A1 | Copolymers with (meth)acrylamides; improved separation of polynucleotides | POLI, PCNA, POLL | LMNA 779/4885KDM4C 4030/4885KDM4A 3673/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.